info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Artificial Coma Medically Induced Coma Companies

The induction of a medically induced coma, also known as therapeutic hypothermia or targeted temperature management, is a medical intervention used to manage severe medical conditions such as traumatic brain injury, cardiac arrest, and certain neurological conditions. While the process involves the use of sedatives and cooling techniques to lower the body's temperature, there isn't a specific industry focused solely on artificial coma. However, companies involved in critical care, medical devices, and neurology may offer products or technologies related to therapeutic hypothermia. 

Artificial Coma/Medically Induced Coma Key Companies

 

Latest Artificial Coma/Medically Induced Coma Companies Update


Bardem Pharmaceuticals, a rising player in the field, received a breakthrough designation from the FDA for its novel drug BPD-123 for inducing and maintaining MIC. This drug aims to offer improved control and reduced side effects compared to traditional barbiturates.


Medtronic, a leading medical device company, introduced its BrainSense system, designed to monitor brain activity and vital signs in patients under MIC. This AI-powered system aims to provide real-time insights for better decision-making and improved patient outcomes.


Researchers from MIT and Harvard Medical School published a study in Nature Medicine demonstrating a novel technique for controlled awakening from MIC. This method utilizes targeted electrical stimulation to specific brain regions, potentially leading to safer and faster recovery.


Several clinical trials are underway exploring the potential of MIC in treating conditions beyond its traditional use for intracranial hypertension and status epilepticus. These include investigations for treating severe traumatic brain injuries, drug-resistant epilepsy, and even certain neurodegenerative diseases.


List of Artificial Coma/Medically Induced Coma Key Companies in the Market



  • Piramal Group

  • Teva Pharmaceutical Industries Ltd.

  • Hikma Pharmaceuticals, Fresenius Se & Co Kgaa

  • Astrazeneca Plc

  • Reddy’s Laboratory

  • Pfizer Inc.

  • Viatris Inc. (Mylan N.V)

  • Braun Melsungen Ag

  • Baxter International Inc.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.